<DOC>
	<DOCNO>NCT02189395</DOCNO>
	<brief_summary>The goal current study determine difference glycemic control traditional split mix regimen Neutral Protamine Hagedorn ( NPH ) regular insulin v basal bolus regimen glargine humalog population type 2 diabetes commonly encounter investigator county hospital set include newly diagnose type 2 patient patient relatively high dose insulin ( dose &gt; 0.4 units/kg body weight . Primary outcome study determine difference glycemic control treatment group measure mean daily blood glucose . Secondary outcome measure number hypoglycemic event , number severe hypoglycemia length hospital stay .</brief_summary>
	<brief_title>Comparison Neutral Protamine Hagedorn ( NPH ) Lantus Based Insulin Regimen Management Hypoglycemia Hospitalized Patients Noncritical Care Setting</brief_title>
	<detailed_description>The effect insulin depend pharmacokinetics pharmacodynamics particular preparation , also patient specific factor include state inflammation , obesity etc . Although effect glucose disposal central insulin action , could differences insulin action metabolic parameter . It known difference suppression inflammation improve glycemic control could vary analog insulin . It unknown natural insulin ( NPH , recombinant human insulin protamine ) differs insulin analog ( glargine detemir , make substitute amino acid native sequence ) term metabolic outcome glucose disposal . At point uncertain clear benefit use lantus NPH inpatient glycemic management . Currently , lantus NPH base regimen practice inpatient hospital setting . Current practice inpatient insulin regimen base familiarity physician particular insulin type personal preference rather evidence base knowledge . Lantus expensive insulin preparation compare NPH uncertain benefit inpatient set . Current research proposal compare two insulin base regimen management diabetes hospitalized patient . Information obtain research guide investigator practice institution well institution .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Patients type II diabetes regardless duration diagnosis admission blood glucose level 140 mg/dL 400 mg/dL include study . Other inclusion criterion follow : age 1880 year old treat diet alone combination oral antidiabetic agent insulin treatment dosage admission . Hyperglycemia without know history diabetes H/o recent cardiac surgery ( within 6 month ) Impaired renal function ( glomerular filtration rate le 45 ) History diabetic ketoacidosis Diabetes mellitus type 1 Pregnancy Patients steroid treatment Known hypopituitarism adrenal insufficiency Known hypoglycemia unawareness Length stay &lt; 48 h And severe liver disease patent admit intensive care unit . Patients already receive insulin dose great 0.5 units/kg body weight admission prior initiation study protocol exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Uncontrolled blood glucose</keyword>
	<keyword>insulin</keyword>
	<keyword>glargine</keyword>
	<keyword>NPH</keyword>
</DOC>